Results 1 to 10 of about 281,835 (235)

PET/CT Radiomic Features: A Potential Biomarker for EGFR Mutation Status and Survival Outcome Prediction in NSCLC Patients Treated With TKIs

Frontiers in Oncology, 2022
BackgroundsEpidermal growth factor receptor (EGFR) mutation profiles play a vital role in treatment strategy decisions for non–small cell lung cancer (NSCLC).
Liping Yang, Panpan Xu, Mengyue Li, Menglu Wang, Mengye Peng, Ying Zhang, Tingting Wu, Wenjie Chu, Kezheng Wang, Hongxue Meng, Lingbo Zhang   +10 more
doaj   +1 more source

Radiomics Analysis of Contrast-Enhanced CT Predicts Survival in Clear Cell Renal Cell Carcinoma

Frontiers in Oncology, 2021
PurposeTo develop and validate the radiomics nomogram that combines clinical factors and radiomics features to estimate overall survival (OS) in patients with clear cell renal cell carcinoma (ccRCC), and assess the incremental value of radiomics for OS ...
Lei Yan, Guangjie Yang, Jingjing Cui, Wenjie Miao, Yangyang Wang, Yujun Zhao, Ning Wang, Aidi Gong, Na Guo, Pei Nie, Zhenguang Wang   +10 more
doaj   +1 more source

Precision low-dose brachytherapy of prostate cancer under PSMA-receptor molecular visualization [PDF]

Digital Diagnostics, 2023
Brachytherapy with implantation of micro sources based on isotope 125I is a preferred treatment for localized prostate cancer without signs of germination of the gland capsule and in the absence of signs of metastases (stage cT1-T23aN0M0).
Pavel V. Sviridov, Pavel O. Rumiantsev, Mikhail V. Degtyarev, Sergey S. Serzhenko, Dmitry B. Sanin, Sergey V. Styrov, Dmitry Yu. Agibalov, Sergey V. Korenev   +7 more
doaj   +1 more source

Predictive value of baseline metabolic tumor burden on 18F-FDG PET/CT for brain metastases in patients with locally advanced non-small-cell lung cancer

Frontiers in Oncology, 2022
ObjectivesBrain metastases (BMs) are a major cause leading to the failure of treatment management for non-small-cell lung cancer (NSCLC) patients. The purpose of this study was to evaluate the predictive value of baseline metabolic tumor burden on 18F ...
Jingjie Shang, Huimin You, Chenchen Dong, Yingxin Li, Yong Cheng, Yongjin Tang, Bin Guo, Jian Gong, Xueying Ling, Hao Xu   +9 more
doaj   +1 more source

The role of artificial intelligence based on PET/CT radiomics in NSCLC: Disease management, opportunities, and challenges

Frontiers in Oncology, 2023
ObjectivesLung cancer has been widely characterized through radiomics and artificial intelligence (AI). This review aims to summarize the published studies of AI based on positron emission tomography/computed tomography (PET/CT) radiomics in non-small ...
Qiuyuan Hu, Ke Li, Conghui Yang, Yue Wang, Rong Huang, Mingqiu Gu, Yuqiang Xiao, Yunchao Huang, Long Chen   +8 more
doaj   +1 more source

Pre-Operative Prediction of Mediastinal Node Metastasis Using Radiomics Model Based on 18F-FDG PET/CT of the Primary Tumor in Non-Small Cell Lung Cancer Patients

Frontiers in Medicine, 2021
Purpose: We investigated whether a fluorine-18-fluorodeoxy glucose positron emission tomography/computed tomography (18F-FDG PET/CT)-based radiomics model (RM) could predict the pathological mediastinal lymph node staging (pN staging) in patients with ...
Kai Zheng, Kai Zheng, Kai Zheng, Xinrong Wang, Chengzhi Jiang, Yongxiang Tang, Zhihui Fang, Jiale Hou, Zehua Zhu, Shuo Hu, Shuo Hu, Shuo Hu   +11 more
doaj   +1 more source

Identification of Stage IIIC/IV EGFR-Mutated Non-Small Cell Lung Cancer Populations Sensitive to Targeted Therapy Based on a PET/CT Radiomics Risk Model

Frontiers in Oncology, 2021
ObjectivesThis project aimed to construct an individualized PET/CT prognostic biomarker to accurately quantify the progression risk of patients with stage IIIC-IV epidermal growth factor receptor (EGFR)-mutated Non-small cell lung cancer (NSCLC) after ...
Dan Shao, Dongyang Du, Haiping Liu, Jieqin Lv, You Cheng, Hao Zhang, Wenbing Lv, Shuxia Wang, Lijun Lu   +8 more
doaj   +1 more source

Case report: Urothelial carcinoma of the renal pelvis with trophoblastic differentiation: A rare case report and review of literature

Pathology and Oncology Research, 2023
We report a rare case of urothelial carcinoma (UC) of the renal pelvis with trophoblastic differentiation that occurred in a 55-year-old male patient. The patient presented with gross hematuria and paroxysmal lumbago pain 5 months ago.
Zhuo Wang, Jinsui Wang, Wenwen Zhang, Daoying Wang, Xiaojun Wang, Xiaoqin Liang   +5 more
doaj   +1 more source

An exploratory study of CT radiomics using differential network feature selection for WHO/ISUP grading and progression-free survival prediction of clear cell renal cell carcinoma

Frontiers in Oncology, 2022
ObjectivesTo explore the feasibility of predicting the World Health Organization/International Society of Urological Pathology (WHO/ISUP) grade and progression-free survival (PFS) of clear cell renal cell cancer (ccRCC) using the radiomics features (RFs)
Fu Yin, Haijie Zhang, Haijie Zhang, Anqi Qi, Zexuan Zhu, Liyang Yang, Ge Wen, Weixin Xie   +7 more
doaj   +1 more source

Comparison of 68Ga-DOTA-NaI3-Octreotide/tyr3-octreotate positron emission tomography/computed tomography and contrast-enhanced computed tomography in localization of tumors in multiple endocrine neoplasia 1 syndrome

World Journal of Nuclear Medicine, 2020
The optimum imaging modality for the screening of multiple endocrine neoplasia type 1 (MEN1)-associated tumors is not well established. Here, we compare the performance of contrast-enhanced CT (CECT) versus 68Ga DOTA-NOC/TATE PET/CT in MEN1 patients. The
Virendra Patil, Manjunath Goroshi, Hina Shah, Gaurav Malhotra, Priya Hira, Vijaya Sarathi, Vikram Lele, Swati Jadhav, Anurag Lila, Tushar Bandgar, Nalini Shah   +10 more
doaj   +1 more source